Harry Kovelman is Chief Medical Officer at MYOMO, INC. (MYO). They have made 9 open-market trades across 1 company since 2024, most recently 2026-10-13.
CIK 0001853204
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYO | 122,389 | $149K |
Shares reported on the most recent Form 4, priced at the 2026-10-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYO | SELL | 2026-09-11 | 2026-10-15 | $1.27 | $20K | N/A | — | — |
| MYO | SELL | 2026-09-11 | 2026-09-14 | $1.27 | $20K | +27.9% | -3.9% | — |
| MYO | SELL | 2026-08-20 | 2026-08-21 | $1.73 | $30K | -16.8% | -8.0% | — |
| MYO | SELL | 2026-08-20 | 2026-08-24 | $1.73 | $30K | -1.1% | +16.7% | — |
| MYO | SELL | 2026-05-27 | 2026-05-28 | $1.01 | $32K | +23.9% | +4.7% | +44.6% |
| MYO | SELL | 2025-03-12 | 2025-03-13 | $5.50 | $165K | +4.3% | -13.4% | -44.4% |
| MYO | SELL | 2024-09-05 | 2024-09-09 | $3.76 | $25K | -3.5% | -2.3% | +58.9% |
| MYO | SELL | 2024-09-03 | 2024-09-05 | $4.01 | $8K | +3.4% | +0.0% | +40.8% |
| MYO | SELL | 2024-05-15 | 2024-05-17 | $3.69 | $261K | -4.4% | -8.5% | +3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.